Concepedia

Todd C. Zion

TC

Statistics

Publications

5

Citations

113

H-Index

5

Active since

2003

Affiliations

Akston Biosciences (United States)(Current)

Baylor College of Medicine

University of California, Davis

Texas Children's Hospital

University Medical Center Groningen

Todd C. Zion is an author at Akston Biosciences (United States) specializing in infectious diseases, oil-in-water adjuvants, and vaccinology.

ORCID

Publications per year

2003–2023

5

Publications

5

Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452

David G. Alleva, Andrea R. Delpero, Melanie Scully et al. · Vaccine · 2021 · 45 citations · Full text

, , +17

Ultra-long-acting recombinant insulin for the treatment of diabetes mellitus in dogs

Sean E. Hulsebosch, Jully Pires, Michael J. Bannasch et al. · Journal of Veterinary Internal Medicine · 2022 · 24 citations · Full text

, , +16

Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452

Yester F. Janssen, Eline A. Feitsma, Hendrikus H. Boersma et al. · Vaccine · 2022 · 17 citations · Full text

, , +17

A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452

Eline A. Feitsma, Yester F. Janssen, Hendrikus H. Boersma et al. · Vaccine · 2023 · 16 citations · Full text

, , +17

Glucose-Sensitive Nanoparticles for Controlled Insulin Delivery

Todd C. Zion, Henry H. Tsang, Jackie Y. Ying · DSpace@MIT (Massachusetts Institute of Technology) · 2003 · 11 citations · Full text

, , +17

1–5 of 5